Status:

UNKNOWN

HA-WBRT vs SRS in Patients With Multiple Brain Metastases

Lead Sponsor:

Medical University Innsbruck

Conditions:

Brain Metastases

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This study compares the effectiveness and safety of two radiation treatment techniques for patients with multiple brain metastases.

Detailed Description

For patients suffering from multiple brain metastases whole brain radiation therapy still constitutes a standard therapy. However, because of the risk of neurocognitive side effects as well as reduced...

Eligibility Criteria

Inclusion

  • At least 4 and not exceeding 15 brain metastases not exceeding a combined total volume of 25ml and not previously treated with radiotherapy
  • KPI ≥ 70, ECOG ≤ 2
  • Age ≥ 18 years, Male or female

Exclusion

  • Neuroendocrine, SCLC, germinoma or lymphoma histology
  • Brain stem metastasis
  • Life expectancy \< 3 months
  • Suspicion of meningeosis carcinomatosa
  • Previous WBRT
  • Inability to participate in radiologic follow-up, contraindication to MR imaging (e.g. not MRI compatible pacemaker, severe claustrophobia)
  • Inability to participate in neurocognitive function testing, insufficient German language skills, aphasia, graphomotor impairment, insufficient vision, insufficient attention span
  • Pregnancy, nursing or unwillingness to prevent pregnancy using effective methods of contraception during treatment
  • Known abuse of medication, drugs or alcohol
  • Known severe dementia (z-score \< 2) or major cognitive function disorder that is not caused by intracranial tumour
  • Known clinical depression or psychotic disorder

Key Trial Info

Start Date :

February 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2023

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04277403

Start Date

February 15 2020

End Date

February 1 2023

Last Update

September 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University Innsbruck

Innsbruck, Austria, 6020

HA-WBRT vs SRS in Patients With Multiple Brain Metastases | DecenTrialz